Member Exclusive News

The week in industry: First and only gene therapy approved for pediatric patients with SMA

This week: Eli Lilly (IN, USA) set to acquire worldwide rights for non-opioid pain treatment, data shows that the UK is a world leader in vaccine exports and the EMA has accepted a Marketing Authorization Application for a trastuzumab biosimilar.

May 30, 2019
0
0

Please sign in or register for FREE

No comments yet.